These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17515696)

  • 1. The pharmacokinetics of cinacalcet are unaffected following consumption of high- and low-fat meals.
    Padhi D; Salfi M; Harris RZ
    Am J Ther; 2007; 14(3):235-40. PubMed ID: 17515696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic properties of the calcimimetic agent cinacalcet (KRN1493) in healthy male Korean subjects: a randomized, open-label, single ascending-dose, parallel-group study.
    Lee S; Gu N; Kim BH; Lim KS; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 May; 34(5):1160-9. PubMed ID: 22503212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
    Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
    Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults.
    Musson DG; Kramer WG; Foehr ED; Bieberdorf FA; Hornfeldt CS; Kim SS; Dorenbaum A
    Clin Ther; 2010 Feb; 32(2):338-46. PubMed ID: 20206791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteers.
    Padhi D; Salfi M; Emery M
    Drugs R D; 2008; 9(5):335-43. PubMed ID: 18721002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
    Godfrey AR; Digiacinto J; Davis MW
    Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study.
    Krishnan S; Zhang Y
    J Clin Pharmacol; 2008 Mar; 48(3):293-302. PubMed ID: 18285619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of different meal compositions on the oral bioavailability of treprostinil diolamine in healthy volunteers.
    Lim A; Wang-Smith L; Kates J; Laurent A; Kumar P; Laliberte K
    J Clin Pharm Ther; 2013 Dec; 38(6):450-5. PubMed ID: 23927483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads.
    Damle BD; Yan JH; Behr D; O'Mara E; Nichola P; Kaul S; Knupp C
    J Clin Pharmacol; 2002 Apr; 42(4):419-27. PubMed ID: 11936567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of cinacalcet in hepatic impairment : phase I, open-label, parallel-group, single-dose, single-centre study.
    Padhi D; Harris RZ; Salfi M; Noveck RJ; Sullivan JT
    Clin Drug Investig; 2008; 28(10):635-43. PubMed ID: 18783302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of food on pharmacokinetics of an inhaled drug: a case study with a VLA-4 antagonist, HMR1031.
    Shah B; Jensen BK; Zhang J; Hunt T; Rohatagi S
    J Clin Pharmacol; 2003 Dec; 43(12):1341-9. PubMed ID: 14615470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers.
    Pithavala YK; Chen Y; Toh M; Selaru P; LaBadie RR; Garrett M; Hee B; Mount J; Ni G; Klamerus KJ; Tortorici MA
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):103-12. PubMed ID: 22644797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects.
    Kovarik JM; Schmouder R; Barilla D; Wang Y; Kraus G
    Br J Clin Pharmacol; 2004 May; 57(5):586-91. PubMed ID: 15089811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a high-fat meal on the oral bioavailability of the immunosuppressant sirolimus (rapamycin).
    Zimmerman JJ; Ferron GM; Lim HK; Parker V
    J Clin Pharmacol; 1999 Nov; 39(11):1155-61. PubMed ID: 10579146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of food on the absorption of oral ziprasidone.
    Miceli JJ; Glue P; Alderman J; Wilner K
    Psychopharmacol Bull; 2007; 40(3):58-68. PubMed ID: 18007569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
    Dong BJ
    Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.